Solution Structure of the Immunodominant Domain of Protective Antigen GNA1870 of Neisseria meningitidis*

GNA1870, a 28-kDa surface-exposed lipoprotein of Neisseria meningitidis recently discovered by reverse vaccinology, is one of the most potent antigens of Meningococcus and a promising candidate for a universal vaccine against a devastating disease. Previous studies of epitope mapping and genetic characterization identified residues critical for bactericidal response within the C-terminal domain of the molecule. To elucidate the conformation of protective epitopes, we used NMR spectroscopy to obtain the solution structure of the immunodominant 18-kDa C-terminal portion of GNA1870. The structure consists of an eight-stranded antiparallel β-barrel overlaid by a short α-helix with an unstructured N-terminal end. Residues previously shown to be important for antibody recognition were mapped on loops facing the same ridge of the molecule. The sequence similarity of GNA1870 with members of the bacterial transferrin receptor family allows one to predict the folding of this class of well known bacterial antigens, providing the basis for the rational engineering of high affinity B cell epitopes.

[1]  R. Rappuoli,et al.  The Region Comprising Amino Acids 100 to 255 of Neisseria meningitidis Lipoprotein GNA 1870 Elicits Bactericidal Antibodies , 2005, Infection and Immunity.

[2]  Frances M. G. Pearl,et al.  The CATH Domain Structure Database and related resources Gene3D and DHS provide comprehensive domain family information for genome analysis , 2004, Nucleic Acids Res..

[3]  M. Comanducci,et al.  Protective Activity of Monoclonal Antibodies to Genome-Derived Neisserial Antigen 1870, a Neisseria meningitidis Candidate Vaccine1 , 2004, The Journal of Immunology.

[4]  Laurence Lins,et al.  Transferrin-Binding Protein B of Neisseria meningitidis: Sequence-Based Identification of the Transferrin-Binding Site Confirmed by Site-Directed Mutagenesis , 2004, Journal of bacteriology.

[5]  P. Güntert Automated NMR structure calculation with CYANA. , 2004, Methods in molecular biology.

[6]  Piet Gros,et al.  Crystal Structure of Neisserial Surface Protein A (NspA), a Conserved Outer Membrane Protein with Vaccine Potential* , 2003, Journal of Biological Chemistry.

[7]  Jeannette Adu-Bobie,et al.  Vaccination against Neisseria meningitidis Using Three Variants of the Lipoprotein GNA1870 , 2003, The Journal of experimental medicine.

[8]  S. Smith‐Gill,et al.  Dissection of binding interactions in the complex between the anti-lysozyme antibody HyHEL-63 and its antigen. , 2003, Biochemistry.

[9]  M. Achtman,et al.  Crystal structure of the OpcA integral membrane adhesin from Neisseria meningitidis , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[10]  R. Mariuzza,et al.  Molecular recognition in antibody-antigen complexes. , 2002, Advances in protein chemistry.

[11]  K. Tanizawa,et al.  Structure of a quinohemoprotein amine dehydrogenase with an uncommon redox cofactor and highly unusual crosslinking , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[12]  L. Wyns,et al.  Degenerate interfaces in antigen-antibody complexes. , 2001, Journal of molecular biology.

[13]  T. Popović,et al.  exl, an Exchangeable Genetic Island in Neisseria meningitidis , 2001, Infection and Immunity.

[14]  K. Kano,et al.  New pathway of amine oxidation respiratory chain of Paracoccus denitrificans IFO 12442. , 2001, European journal of biochemistry.

[15]  Gottfried Otting,et al.  Alignment of Biological Macromolecules in Novel Nonionic Liquid Crystalline Media for NMR Experiments , 2000 .

[16]  A. Cripps,et al.  Immunization with Recombinant Transferrin Binding Protein B Enhances Clearance of Nontypeable Haemophilus influenzae from the Rat Lung , 1999, Infection and Immunity.

[17]  J. Tappero,et al.  Immunogenicity of 2 serogroup B outer-membrane protein meningococcal vaccines: a randomized controlled trial in Chile. , 1999, JAMA.

[18]  A. Schryvers,et al.  Identification of sequences in human transferrin that bind to the bacterial receptor protein, transferrin‐binding protein B , 1999, Molecular microbiology.

[19]  A. Rosato,et al.  Partial Orientation of Oxidized and Reduced Cytochrome b5 at High Magnetic Fields: Magnetic Susceptibility Anisotropy Contributions and Consequences for Protein Solution Structure Determination , 1998 .

[20]  C Sander,et al.  Dictionary of recurrent domains in protein structures , 1998, Proteins.

[21]  M. Klein,et al.  The Transferrin Binding Protein B of Moraxella catarrhalis Elicits Bactericidal Antibodies and Is a Potential Vaccine Antigen , 1998, Infection and Immunity.

[22]  A. Bax,et al.  Measurement of J and dipolar couplings from simplified two-dimensional NMR spectra. , 1998, Journal of magnetic resonance.

[23]  B. Plikaytis,et al.  Immunogenicity of two efficacious outer membrane protein-based serogroup B meningococcal vaccines among young adults in Iceland. , 1998, The Journal of infectious diseases.

[24]  N. Cadieux,et al.  Highly Conserved Neisseria meningitidis Surface Protein Confers Protection against Experimental Infection , 1997, The Journal of experimental medicine.

[25]  J. Thornton,et al.  AQUA and PROCHECK-NMR: Programs for checking the quality of protein structures solved by NMR , 1996, Journal of biomolecular NMR.

[26]  S. Gray-Owen,et al.  Bacterial transferrin and lactoferrin receptors. , 1996, Trends in microbiology.

[27]  D. Ala'aldeen,et al.  The meningococcal transferrin-binding proteins 1 and 2 are both surface exposed and generate bactericidal antibodies capable of killing homologous and heterologous strains. , 1996, Vaccine.

[28]  E. Rosenqvist,et al.  Human antibody responses to meningococcal outer membrane antigens after three doses of the Norwegian group B meningococcal vaccine , 1995, Infection and immunity.

[29]  Peter A. Kollman,et al.  AMBER, a package of computer programs for applying molecular mechanics, normal mode analysis, molecular dynamics and free energy calculations to simulate the structural and energetic properties of molecules , 1995 .

[30]  P. Dumas,et al.  Evaluation of transferrin-binding protein 2 within the transferrin-binding protein complex as a potential antigen for future meningococcal vaccines , 1995, Infection and immunity.

[31]  B. Sykes,et al.  Quantification of the calcium‐induced secondary structural changes in the regulatory domain of troponin‐C , 1994, Protein science : a publication of the Protein Society.

[32]  T. Pawson,et al.  Backbone dynamics of a free and phosphopeptide-complexed Src homology 2 domain studied by 15N NMR relaxation. , 1994, Biochemistry.

[33]  S. Grzesiek,et al.  Measurement of homo- and heteronuclear J couplings from quantitative J correlation. , 1994, Methods in enzymology.

[34]  T. Blundell,et al.  Comparative protein modelling by satisfaction of spatial restraints. , 1993, Journal of molecular biology.

[35]  S. Grzesiek,et al.  The Importance of Not Saturating H2o in Protein NMR : application to Sensitivity Enhancement and Noe Measurements , 1993 .

[36]  C. Sacchi,et al.  Protective efficacy of a serogroup B meningococcal vaccine in Sao Paulo, Brazil , 1992, The Lancet.

[37]  Jeffrey W. Peng,et al.  Mapping of Spectral Density Functions Using Heteronuclear NMR Relaxation Measurements , 1992 .

[38]  A. Halstensen,et al.  Effect of outer membrane vesicle vaccine against group B meningococcal disease in Norway , 1991, The Lancet.

[39]  C. Frasch Vaccines for prevention of meningococcal disease , 1989, Clinical Microbiology Reviews.

[40]  M. Artenstein,et al.  HUMAN IMMUNITY TO THE MENINGOCOCCUS : III. PREPARATION AND IMMUNOCHEMICAL PROPERTIES OF THE GROUP A, GROUP B, AND GROUP C MENINGOCOCCAL POLYSACCHARIDES , 1969 .

[41]  S. Branham,et al.  Serological relationships among meningococci. , 1953, Bacteriological reviews.